X4 Pharmaceuticals (NASDAQ: XFOR)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of X4 Pharmaceuticals (NASDAQ: XFOR) through any online brokerage.
The latest price target for X4 Pharmaceuticals (NASDAQ: XFOR) was reported by B. Riley Securities on Thursday, May 19, 2022. The analyst firm set a price target for 7.00 expecting XFOR to rise to within 12 months (a possible 625.39% upside). 4 analyst firms have reported ratings in the last year.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.965 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.